Evidence map›Paper›PMID 41071551›Full record

Trial reportJAMA network open2025

Air Purifier Intervention for Respiratory Viral Exposure in Elementary Schools: A Secondary Analysis of a Randomized Clinical Trial.

Ye Sun, Dastan Haghnazari, Ching-Ying Huang, Aribah Baig, Minsik Kim, Amparito Cunningham, Colin Skeen, Jack M Wolfson, Stephen T Ferguson, Erica D Pratt and 7 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Mitigating indoor risk of airborne infections using COJournal of environmental health science & engineering · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ye SunDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.
Dastan HaghnazariDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.
Ching-Ying HuangDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.
Aribah BaigDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.
Minsik KimDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.
Amparito CunninghamDivision of Allergy and Immunology, Boston Children's Hospital, Boston, Massachusetts.
Colin SkeenDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts.
Jack M WolfsonDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Stephen T FergusonDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Erica D PrattDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts.
Linda ValeriDepartment of Biostatistics, Columbia Mailman School of Public Health, New York, New York.
Sophia ZhaoDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.
Diane R GoldDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Leonora BalajDepartment of Neurosurgery, Massachusetts General Hospital, Boston.
Petros KoutrakisDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Wanda PhipatanakulDivision of Allergy and Immunology, Boston Children's Hospital, Boston, Massachusetts.
Peggy S LaiDivision of Pulmonary and Critical Care, Massachusetts General Hospital, Boston.

Funding

SICAS- Diversity SupplementU01AI110397 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2015 to 2020
$8.8M
The school microbiome and asthma morbidity in inner-city childrenR01AI144119 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LAI, PEGGY SUE · 2019 to 2023
$3.7M
Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s HospitalU01AI160087 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI Talal Amine Chatila, WANDA PHIPATANAKUL · 2021 to 2026
$2.8M
High efficiency particulate air cleaner intervention to reduce respiratory virus exposure in elementary schoolsR21AI178155 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LAI, PEGGY SUE · 2023 to 2024
$490k
Molecular epidemiology of respiratory virus exposure in elementary schoolsR21AI175965 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LAI, PEGGY SUE · 2023 to 2024
$481k
Metagenomic Profiling of Dust Samples for School-based Viral SurveillanceF32AI194859 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI Ye Sun · 2025 to 2026
$188k
NIAID NIH HHS F32 AI194859NIAID NIH HHS R01 AI144119NIAID NIH HHS R21 AI175965NIAID NIH HHS R21 AI178155NIAID NIH HHS U01 AI110397NIAID NIH HHS U01 AI160087
6 · The paper itself

Abstract

Importance: The magnitude of school respiratory virus exposure and the effectiveness of environmental mitigation measures remain unclear. Objective: To evaluate whether portable high-efficiency particulate air (HEPA) purifiers are associated with reduced respiratory virus exposure in elementary school classrooms. Design, Setting, and Participants: This ad hoc secondary analysis was performed between July 2023 and September 2024 and used data from a cluster-randomized, placebo-controlled trial (School Inner-City Asthma Intervention Study) of HEPA purifiers conducted from September 2015 to June 2020. A total of 200 classrooms from 39 public schools in Northeastern US were enrolled and randomized. Interventions: Classrooms were randomized 1:1 to receive either active HEPA purifiers or visually identical sham HEPA units (4 per classroom). School staff and investigators were blinded to intervention assignments. Main Outcomes and Measures: The primary outcome was high viral exposure, identified by K-means clustering of individual viral concentrations. Secondary outcomes included viral diversity (defined as number of detected virus types) and individual viral concentrations. Week-long bioaerosol samples were collected 3 times during 1 school year, and concentrations of 19 respiratory viruses were quantified by digital droplet polymerase chain reaction. Results: Of the 200 enrolled classrooms (91 in the sham purifier group and 109 in the HEPA purifier group) analyzed, the median (IQR) class size was 19 (18-20) and the median (IQR) grade was 3 (2-5). A total of 532 bioaerosol samples were collected; viruses were detected in 524 samples (98.5%), with a median (IQR) of 3 (2-5) viruses per classroom. Rhinovirus was most prevalent (476 [89.5%]), while respiratory syncytial virus A and B (66 [12.4%] and 127 [23.9%]) as well as influenza A and B (94 [17.7%] and 76 [14.3%]) were also detected. High viral exposure was present in 118 samples (22.2%). The HEPA purifier intervention was not associated with lower odds of high viral exposure (odds ratio [OR], 0.50; 95% CI, 0.08-3.25; P = .46) but did correspond to a modest reduction in viral diversity (β = -1.02; 95% CI, -1.68 to -0.35; P = .003). Elastic net regression identified relative humidity, grade, winter season, and coarse particulate matter as the environmental risk factors for viral exposure. Conclusions and Relevance: In this secondary analysis, HEPA purifiers were not associated with a reduction in high viral exposure but were associated with a modest decrease in viral diversity. Multicomponent interventions may be needed to mitigate respiratory viral exposures in schools.

Indexed as

Air FiltersAir Pollution, IndoorRespiratory Tract InfectionsSchoolsChildFemaleHumansMale

Identifiers

PMID41071551
PMCPMC12514627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.